Next Generation Sequencing (NGS)

Research Services

Next-generation Sequencing (NGS)

Next-Generation Sequencing (NGS) offers unparalleled precision in genomic analysis and molecular diagnostics. Its ability to simultaneously analyze hundreds of genes enables comprehensive tumor profiling and biomarker discovery with exceptional sensitivity and accuracy. NGS is widely used for solid tumor profiling, hereditary cancer testing, and personalized medicine applications. Its robust performance, reproducibility, and ability to deliver actionable insights make it an indispensable tool for advancing clinical care and biopharmaceutical research.

Our Expertise

We have been providing NGS services with deep expertise in translational science, automation, and advanced analytics. Our laboratory is built to integrate seamlessly into clinical and research pipelines, positioning ourselves as leaders in delivering clinical-grade results on research timelines. Over the years, we have extensively processed tens of thousands of patient specimens for public health surveillance and clinical trial samples from around the world.

Application Description
Cyx Solid Tumor 505 FDA-cleared and CE-IVD-marked comprehensive tumor profiling that enables rapid and actionable genomic insights for all patients with advanced cancer. This panel affords every patient access to personalized treatment options through comprehensive analysis of DNA and RNA targets.
Custom Assay Design & Validation Tailored NGS assays designed for specific research applications, including targeted gene panels, whole exome sequencing, and transcriptome analysis. Custom panels validated for clinical-grade accuracy with rapid turnaround times.
Biomarker Discovery High-throughput NGS workflows optimized for identifying novel therapeutic targets and companion diagnostics. Enhanced precision for drug development and clinical trial support with harmonized chemistries and automated bioinformatics pipelines.
Hereditary Cancer Testing Comprehensive genetic testing for inherited cancer predisposition genes, enabling proactive clinical management and family screening programs with expert genetic counseling support.
Pharmacogenomics NGS-based analysis of drug metabolism genes to optimize therapeutic selection and dosing, supporting personalized medicine initiatives across multiple therapeutic areas.